Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Which passive funds are cheap for retirement? Focus on low-fee, diversified funds to maximize long-term growth with predictable costs.
23,256 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Tesla's China Sales Just Jumped 22% in May, ending a slump. This article breaks down what's behind the rebound, wheth...
Stitch Fix surprised investors with stronger-than-expected results, sparking a notable market move. This article brea...
CoreWeave stock recently jumped on fresh analyst optimism and AI-fueled demand for data center capacity. This guide b...
When the tech rally paused, AI leaders pulled back too. This guide spotlight three robust bets for long-term gains, p...
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Cerebras' first earnings report brings a clear message for AI stock shoppers: growth alone isn't enough. Here's how t...
When headlines shout about a stalled housing bill, borrowers can feel exposed. This article breaks down what the stal...
AT&T and Verizon report Q1 2026 results as fiber deals reshape their paths. This analysis weighs dividends, cash flow...
Mastercard posts strong Q1 2026 results with rising services and margins, while PayPal signals a flat-to-down 2026. T...
AI stocks have cooled, but durable leaders still offer big upside. This guide highlights three genius artificial inte...
Stock splits grab headlines, but the real question for investors is whether the move changes the investment case. Thi...